MOLDIAG, A SPIN-OFF OF THE MAScIR FOUNDATION OF UM6P, LAUNCHES THE FIRST 100% MOROCCAN TEST FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA
MOLDIAG, A SPIN-OFF OF THE MAScIR FOUNDATION OF UM6P, LAUNCHES THE FIRST 100% MOROCCAN TEST FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA Chronic myeloid leukemia (CML) is a type of blood cancer characterized by an excessive production of granulocytes (a type of white blood cell) by the bone marrow. The diagnostic and therapeutic management (closely linked) of…